Skip to main content
SpringerLink
Log in

Pharmacokinetics and dosage recommendations of teicoplanin in patients treated by continuous veno-venous haemodialysis (CVVHD)

  • Letter to the Editors
  • Published:
European Journal of Clinical Pharmacology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Bonati M, Traina GL, Villa G, Salvadeo A, Gentile MG, Fellin G, Rosina R, Cavenaghi L, Buniva G (1987) Teicoplanin pharmacokinetics in patients with chronic renal failure. Clin Pharmacokinet 12: 292–301

    Google Scholar 

  2. Höffler D, Koeppe P, Naumann E, Lang E, Sörgel F (1991) Pharmacokinetics of teicoplanin in hemodialysis patients. Infection 19: 324–327

    Google Scholar 

  3. Brodersen H-P, Beckers B, Stolpmann RM, Larbig D, Jansen G (1990) Teicoplanin-Therapie bei Hämodialyse. ZAC Z Anti-mikrob Antineoplast Chemother 8: 39–42

    Google Scholar 

  4. Rybak MJ, Reddy VN, Matzke GR, Awni WM, Peter WS, Mastin SH, Mayer GD, Kenny MT and FPIA Study Group (1989) Teicoplanin fluorescence polarization immunoassay. Pharmacotherapy 9: 188

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Internal Medicine, Section of Renal and Hypertensive Diseases, University Hospital Essen, Essen, Germany

    K. Wolter, M. Claus & E. Fritschka

Authors
  1. K. Wolter
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. M. Claus
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. E. Fritschka
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Wolter, K., Claus, M. & Fritschka, E. Pharmacokinetics and dosage recommendations of teicoplanin in patients treated by continuous veno-venous haemodialysis (CVVHD). Eur J Clin Pharmacol 46, 179–180 (1994). https://doi.org/10.1007/BF00199886

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00199886

Key words

Search

Navigation